Orient Europharma Co Ltd (4120) — Long-term Investment Intensity
Orient Europharma Co Ltd (4120) has a Long-term Investment Intensity of 1.9% as of December 2019. Long-term investments of NT$145.70 Million represent 1.9% of total assets of NT$7.87 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Orient Europharma Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Orient Europharma Co Ltd Long-term Investment Intensity (2015–2019)
This chart shows how Orient Europharma Co Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2015 to 2019. As of December 2019, the intensity stands at 1.9%, reflecting long-term investments of NT$145.70 Million against total assets of NT$7.87 Billion TWD. For the complete balance sheet picture, see how large is Orient Europharma Co Ltd's balance sheet.
Annual Long-term Investment Intensity for Orient Europharma Co Ltd (2015–2019)
The table below presents the year-by-year Long-term Investment Intensity for Orient Europharma Co Ltd from 2015 to 2019, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Orient Europharma Co Ltd (4120) financial obligations for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 1.9% | NT$145.70 Million | NT$7.87 Billion | ▲ +0.4 pp |
| 2018 | 1.5% | NT$107.30 Million | NT$7.24 Billion | ▼ -1.4 pp |
| 2017 | 2.9% | NT$192.14 Million | NT$6.65 Billion | ▼ -1.1 pp |
| 2016 | 4.0% | NT$256.66 Million | NT$6.49 Billion | ▼ -0.6 pp |
| 2015 | 4.5% | NT$248.16 Million | NT$5.47 Billion | — |